- Home
- DVAX vs RXO Comparison
DVAX vs RXO Comparison
Compare DVAX & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVAX
- RXO
- Stock Information
- Founded
- DVAX 1996
- RXO 2022
- Country
- DVAX United States
- RXO United States
- Employees
- DVAX N/A
- RXO N/A
- Industry
- DVAX Biotechnology: Pharmaceutical Preparations
- RXO
- Sector
- DVAX Health Care
- RXO
- Exchange
- DVAX Nasdaq
- RXO Nasdaq
- Market Cap
- DVAX 1.3B
- RXO 2.7B
- IPO Year
- DVAX 2004
- RXO N/A
- Fundamental
- Price
- DVAX $9.75
- RXO $17.45
- Analyst Decision
- DVAX Buy
- RXO Hold
- Analyst Count
- DVAX 4
- RXO 15
- Target Price
- DVAX $26.50
- RXO $17.77
- AVG Volume (30 Days)
- DVAX 2.0M
- RXO 1.9M
- Earning Date
- DVAX 11-06-2025
- RXO 11-06-2025
- Dividend Yield
- DVAX N/A
- RXO N/A
- EPS Growth
- DVAX N/A
- RXO N/A
- EPS
- DVAX N/A
- RXO N/A
- Revenue
- DVAX $316,268,000.00
- RXO $5,559,000,000.00
- Revenue This Year
- DVAX $23.23
- RXO $31.25
- Revenue Next Year
- DVAX $16.57
- RXO $6.82
- P/E Ratio
- DVAX N/A
- RXO N/A
- Revenue Growth
- DVAX 26.66
- RXO 46.41
- 52 Week Low
- DVAX $9.20
- RXO $12.19
- 52 Week High
- DVAX $14.63
- RXO $31.98
- Technical
- Relative Strength Index (RSI)
- DVAX 43.66
- RXO 59.60
- Support Level
- DVAX $9.20
- RXO $16.34
- Resistance Level
- DVAX $9.94
- RXO $17.94
- Average True Range (ATR)
- DVAX 0.31
- RXO 0.68
- MACD
- DVAX -0.01
- RXO 0.09
- Stochastic Oscillator
- DVAX 50.00
- RXO 78.03
About DVAX Dynavax Technologies Corporation
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.